Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29404403 | 1.00 | SMN1; SMN2 (0.45) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL42033 | 1.00 | SMN1; SMN2 (0.45) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL29564029 | 1.00 | SMN1; SMN2 (0.45) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL179965 | 1.00 | SMN1; SMN2 (0.45) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL1256265 | 0.91 | MEN1 (0.49) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL29488442 | 0.90 | PTGDR2 (0.46) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL18191247 | 0.90 | PTGDR2 (0.46) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL14637025 | 0.90 | PTGDR2 (0.46) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL14637026 | 0.90 | PTGDR2 (0.46) | SMN1; SMN2MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL8158229 | 0.89 | MRGPRX4 (0.50) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105579-A1 | Plant Health Composition | BASF SE (DE) | 2011-05-05 | — | — | US | claimed |
| JP-2011511033-A | — | — | 2011-04-07 | — | — | JP | claimed |
| US-20100272853-A1 | Method of Increasing the Milk and/or Meat Quantity of Silage-Fed Animals | BASF SE (DE) | 2010-10-28 | — | — | US | claimed |
| EP-2240027-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2010-10-20 | — | — | EP | claimed |
| EP-2234481-A2 | METHOD OF INCREASING THE MILK AND/OR MEET QUANTITY OF SILAGE-FED ANIMALS | BASF SE (DE) | 2010-10-06 | — | — | EP | claimed |
| WO-2009098223-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2009-08-13 | — | — | WO | claimed |
| WO-2009080609-A2 | METHOD OF INCREASING THE MILK AND/OR MEET QUANTITY OF SILAGE-FED ANIMALS | BASF SE (DE) | 2009-07-02 | — | — | WO | claimed |
| EP-4410099-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2024-08-07 | — | — | EP | disclosed |
| EP-4410100-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406412-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2024-07-31 | — | — | EP | disclosed |
| CN-111801014-B | Fungicidal compositions of cloroxen | 巴斯夫农业公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-111801014-B | Fungicidal compositions of cloroxen | 巴斯夫农业公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-111801014-A | Fungicidal compositions of cloroxen | 巴斯夫农业公司 | 2020-10-20 | — | — | CN | disclosed |
| US-20130156932-A1 | Method of increasing the milk and/or meat quantity of silage-fed animals | BASF SE (DE) | 2013-06-20 | — | — | US | disclosed |
| EP-2565180-A2 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Oscotec Inc. (KR) | 2013-03-06 | — | — | EP | disclosed |
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | OSCOTEC INC. (KR) | 2012-06-14 | — | — | US | disclosed |
| US-20110105579-A1 | Plant Health Composition | BASF SE (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20100272853-A1 | Method of Increasing the Milk and/or Meat Quantity of Silage-Fed Animals | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-2234481-A2 | METHOD OF INCREASING THE MILK AND/OR MEET QUANTITY OF SILAGE-FED ANIMALS | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009080609-A2 | METHOD OF INCREASING THE MILK AND/OR MEET QUANTITY OF SILAGE-FED ANIMALS | BASF SE (DE) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | HIF1A, HIF1AN, EGLN3 | SMN1; SMN2 3764/4885MEN1 4558/4885KMT2A 2186/4885 |
| US-20110105579-A1 | Plant Health Composition | GET3, BROX, ATL3 | SMN1; SMN2 2981/4885MEN1 338/4885KMT2A 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.